Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer

This study has been completed.
Aventis Pharmaceuticals
Rhone-Poulenc Rorer
Information provided by (Responsible Party):
University of Michigan Cancer Center Identifier:
First received: September 2, 2005
Last updated: October 3, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2006
  Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)